Metformin ER / working resource

Clinical conversation planner

Bring specific questions and a source record to a qualified clinician.

Start with the product-specific question

The boxed warning

Metformin ER, approved for type 2 diabetes, with the evidence and its limits for other uses in plain view. What should I know about the lactic acidosis warning?

In the 15-year follow-up of the Diabetes Prevention Program Outcomes Study, the cumulative incidences of diabetes at year 15 were 55% in the lifestyle group, 56% in the metformin group, and 62% in the placebo group.
Read the original record ↗

Open the Metformin ER library ↗

Choose the questions that need an answer.

Use the Metformin ER research to prepare a conversation, then let the clinician assess your individual situation. This worksheet does not determine eligibility or treatment.

What should I know about the lactic acidosis warning?What should I know about kidney function and contrast imaging?What should I know about metformin and aging?Which evidence applies to the exact Metformin ER formulation being considered?What alternatives address the same goal, and what evidence supports them?Which risks, interactions and uncertainties matter for this decision?What would count as a useful outcome, and when would it be reassessed?Who should I contact if I have a problem or an unresolved question?The specific goal or uncertainty I want to discuss

Your conversation agenda

Select questions above to create your agenda here.

Source URLs and product documents to bringAnswers, unresolved points and agreed follow-up

Share personal health details only through your care provider's appropriate private channel. This page does not send or save your notes.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗